Cargando…

Local Angiotensin Generation and AT(2) Receptor Activation

Detalles Bibliográficos
Autores principales:	Esch, Joep H.M. Van, Danser, A.H. Jan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2007
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7119946/ http://dx.doi.org/10.1007/978-1-4020-6372-5_12

Ejemplares similares

Renin-Angiotensin System Blockers and the COVID-19 Pandemic: At Present There Is No Evidence to Abandon Renin-Angiotensin System Blockers
por: Danser, A.H. Jan, et al.
Publicado: (2020)

Megalin: a Novel Determinant of Renin-Angiotensin System Activity in the Kidney?
por: Sun, Yuan, et al.
Publicado: (2020)

Prorenin anno 2008
por: Danser, A. H. Jan, et al.
Publicado: (2008)

Impaired Vascular Contractility and Aortic Wall Degeneration in Fibulin-4 Deficient Mice: Effect of Angiotensin II Type 1 (AT(1)) Receptor Blockade
por: Moltzer, Els, et al.
Publicado: (2011)

The Use of Angiotensin II for the Treatment of Post-cardiopulmonary Bypass Vasoplegia
por: Papazisi, Olga, et al.
Publicado: (2020)

Revisiting the Brain Renin-Angiotensin System—Focus on Novel Therapies
por: Ren, Liwei, et al.
Publicado: (2019)

Transforming Growth Factor-β and the Renin-Angiotensin System in Syndromic Thoracic Aortic Aneurysms: Implications for Treatment
por: van Dorst, Daan C.H., et al.
Publicado: (2020)

Functional tests to guide management in an adult with loss of function of type-1 angiotensin II receptor
por: Viering, Daan H. H. M., et al.
Publicado: (2021)

The (pro)renin receptor. A decade of research: what have we learned?
por: Krop, Manne, et al.
Publicado: (2012)

Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers and risk of depression among older people with hypertension
por: van Sloten, Thomas T, et al.
Publicado: (2022)

High Renin Concentrations in Severe COVID-19 Are Indicative for a Hypo–Renin–Angiotensin-System State
por: Akin, Sakir, et al.
Publicado: (2022)

Megalin, Proton Pump Inhibitors and the Renin–Angiotensin System in Healthy and Pre-Eclamptic Placentas
por: Sun, Yuan, et al.
Publicado: (2021)

Kidney Angiotensin in Cardiovascular Disease: Formation and Drug Targeting
por: Lin, Hui, et al.
Publicado: (2022)

Why are mineralocorticoid receptor antagonists cardioprotective?
por: Chai, Wenxia, et al.
Publicado: (2006)

Aldosterone does not require angiotensin II to activate NCC through a WNK4–SPAK–dependent pathway
por: van der Lubbe, Nils, et al.
Publicado: (2012)

Angiotensin-(1-9) ameliorates pulmonary arterial hypertension via angiotensin type II receptor
por: Cha, Seung Ah, et al.
Publicado: (2018)

Renal medullary (pro)renin receptor contributes to angiotensin II-induced hypertension in rats via activation of the local renin–angiotensin system
por: Wang, Fei, et al.
Publicado: (2015)

Angiotensin Type 2 and Mas Receptor Activation Prevents Myocardial Fibrosis and Hypertrophy through the Reduction of Inflammatory Cell Infiltration and Local Sympathetic Activity in Angiotensin II-Dependent Hypertension
por: Castoldi, Giovanna, et al.
Publicado: (2021)

Novel Therapeutic Approaches Targeting the Renin-Angiotensin System and Associated Peptides in Hypertension and Heart Failure
por: Arendse, Lauren B., et al.
Publicado: (2019)

Evolution of Angiotensin Peptides and Peptidomimetics as Angiotensin II Receptor Type 2 (AT2) Receptor Agonists
por: Vasile, Silvana, et al.
Publicado: (2020)

Receptors | Angiotensin Receptors
por: Pardhi, Triveni R., et al.
Publicado: (2021)

Effect of sodium bicarbonate supplementation on the renin-angiotensin system in patients with chronic kidney disease and acidosis: a randomized clinical trial
por: Bovée, Dominique M., et al.
Publicado: (2020)

The Effect of the Thioether-Bridged, Stabilized Angiotensin-(1–7) Analogue Cyclic Ang-(1–7) on Cardiac Remodeling and Endothelial Function in Rats with Myocardial Infarction
por: Durik, Matej, et al.
Publicado: (2012)

What’s new in the renin-angiotensin system?: Angiotensin-converting enzyme 2: a functional receptor for SARS coronavirus
por: Kuhn, J. H., et al.
Publicado: (2004)

Decoding Angiotensin Receptors: TOMAHAQ‐Based Detection and Quantification of Angiotensin Type‐1 and Type‐2 Receptors
por: Cosarderelioglu, Caglar, et al.
Publicado: (2023)

Receptor Interactions of Angiotensin II and Angiotensin Receptor Blockers—Relevance to COVID-19
por: Moore, Graham J., et al.
Publicado: (2021)

Effect of a Stable Angiotensin‐(1–7) Analogue on Progenitor Cell Recruitment and Cardiovascular Function Post Myocardial Infarction
por: Pessôa, Bruno Sevá, et al.
Publicado: (2015)

Long-Term Use of Aldosterone-Receptor Antagonists in Uncontrolled Hypertension: A Retrospective Analysis
por: Jansen, Pieter M., et al.
Publicado: (2011)

Angiotensin-Converting Enzyme 2 and Antihypertensives (Angiotensin Receptor Blockers and Angiotensin-Converting Enzyme Inhibitors) in Coronavirus Disease 2019
por: Sanchis-Gomar, Fabian, et al.
Publicado: (2020)

Individualised therapy of angiotensin converting enzyme (ACE) inhibitors in stable coronary artery disease: overview of the primary results of the PERindopril GENEtic association (PERGENE) study
por: Brugts, J. J., et al.
Publicado: (2011)

Angiotensin Type 2 Receptors: Painful, or Not?
por: Pulakat, Lakshmi, et al.
Publicado: (2020)

Blocking the CGRP Receptor: Differences across Human Vascular Beds
por: de Vries, Tessa, et al.
Publicado: (2023)

Neprilysin Is Required for Angiotensin-(1–7)’s Ability to Enhance Insulin Secretion via Its Proteolytic Activity to Generate Angiotensin-(1–2)
por: Brar, Gurkirat S., et al.
Publicado: (2017)

Neuroprotective effect of an angiotensin receptor type 2 agonist following cerebral ischemia in vitro and in vivo
por: Lee, Seyoung, et al.
Publicado: (2012)

Evidence for Angiotensin II as a Naturally Existing Suppressor for the Guanylyl Cyclase A Receptor and Cyclic GMP Generation
por: Ma, Xiao, et al.
Publicado: (2023)

Adenoviral Delivery of Angiotensin-(1-7) or Angiotensin-(1-9) Inhibits Cardiomyocyte Hypertrophy via the Mas or Angiotensin Type 2 Receptor
por: Flores-Muñoz, Monica, et al.
Publicado: (2012)

Effects of Dapagliflozin on Volume Status When Added to Renin–Angiotensin System Inhibitors
por: Eickhoff, Mie K., et al.
Publicado: (2019)

The Effect of an Angiotensin Receptor Blocker on Arterial Stiffness in Type 2 Diabetes Mellitus Patients with Hypertension
por: Kim, Ji Hyun, et al.
Publicado: (2011)

Angiotensin Converting Enzyme 2, Angiotensin-(1-7), and Receptor Mas Axis in the Kidney
por: Pinheiro, Sergio Veloso Brant, et al.
Publicado: (2012)

Effect of angiotensin receptor blockers and angiotensin converting enzyme 2 on plasma equilibrium angiotensin peptide concentrations in dogs with heart disease
por: Larouche‐Lebel, Éva, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_4veca91vrpvomntmkjs33i75d2